ATC L04 – Immunszuppresszív szerek

L04A Immunszuppresszív szerek L04AA Szelektív immunszuppresszív szerek

|L04AA02 || width="100" | Muromonab-CD3 || width="100" | Muromonab-CD3 |- |L04AA03 || width="100" | Antilimfocita immunoglobulin (ló) || width="100" | Antilymphocyte immunoglobulin (horse) |- |L04AA04 || colspan="2" | Antilimfocita immunoglobulin (nyúl) |- |L04AA06 || width="100" | Mikofenolát-mofetil || width="100" | Mycophenolic acid || Mycophenolas mofetil |- |L04AA10 || width="100" | Szirolimusz || width="100" | Sirolimus |- |L04AA13 || width="100" | Leflunomid || width="100" | Leflunomide |- |L04AA15 || width="100" | Alefacept || width="100" | Alefacept |- |L04AA18 || width="100" | Everolimusz || width="100" | Everolimus |- |L04AA19 || width="100" | Guszperimusz || width="100" | Gusperimus |- |L04AA21 || width="100" | Efalizumab || width="100" | Efalizumab |- |L04AA22 || width="100" | Abetimusz || width="100" | Abetimus |- |L04AA23 || width="100" | Natalizumab || width="100" | Natalizumab |- |L04AA24 || width="100" | Abatacept || width="100" | Abatacept |- |L04AA25 || width="100" | Ekulizumab || width="100" | Eculizumab |- |L04AA26 || width="100" | Belimumab || width="100" | Belimumab |- |L04AA27 || width="100" | Fingolimod || width="100" | Fingolimod |- |L04AA28 || width="100" | Belatacept || width="100" | Belatacept |- |L04AA29 || width="100" | Tofacitinib || width="100" | Tofacitinib |- |L04AA31 || width="100" | Teriflunomid || width="100" | Teriflunomide |- |L04AA32 || width="100" | Apremilaszt || width="100" | Apremilast |- |L04AA33 || width="100" | Vedolizumab || width="100" | Vedolizumab |- |L04AA34 || width="100" | Alemtuzumab || width="100" | Alemtuzumab

L04AB Tumor necrosis factor alpha (TNF-α) inhibitors L04AB01 Etanercept L04AB02 Infliximab L04AB03 Afelimomab L04AB04 Adalimumab L04AB05 Certolizumab pegol L04AB06 Golimumab

L04AC Interleukin inhibitors L04AC01 Daclizumab L04AC02 Basiliximab L04AC03 Anakinra L04AC04 Rilonacept L04AC05 Ustekinumab L04AC06 Mepolizumab L04AC07 Tocilizumab L04AC08 Canakinumab L04AC09 Briakinumab L04AC10 Secukinumab

L04AD Kalcineurin-gátlók

|L04AD01 || width="100" | Ciklosporin || width="100" | Ciclosporin || Ciclosporinum |- |L04AD02 || width="100" | Takrolimusz || width="100" | Tacrolimus |- |L04AD03 || width="100" | Voklosporin || width="100" | Voclosporin

L04AX Egyéb immunszuppresszív szerek

|L04AX01 || width="100" | Azatioprin || width="100" | Azathioprine || Azathioprinum |- |L04AX02 || width="100" | Thalidomid || width="100" | Thalidomide |- |L04AX03 || width="100" | Metotrexát || width="100" | Methotrexate || Methotrexatum |- |L04AX04 || width="100" | Lenalidomid || width="100" | Lenalidomide |- |L04AX05 || width="100" | Pirfenidon || width="100" | Pirfenidone |- |L04AX06 || width="100" | Pomalidomid || width="100" | Pomalidomide

Kategória:Immunszupresszív gyógyszerek L04